[SIZE=2]http://www.fda.gov/CDER/drug/infopage/ppa/[/SIZE]

[SIZE=2]On December 22, 2005 the FDA issued a notice of proposed rulemaking (notice) for over-the-counter (OTC) nasal decongestant and weight control products containing phenylpropanolamine preparations. This proposed rule reclassifies phenylpropanolamine as nonmonograph (Category II) not generally recognized as safe and effective. [/SIZE]